Use of a 532 nm Green Laser for Solar Lentigines: Case Series and Review
Cosmetics · 22.05.2026 · 13 (3) · 128
DOI: 10.3390/cosmetics13030128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cosmetics, online erschienen am 22.05.2026. Verfasst von Elena Zappia und 10 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Solar lentigines are common epidermal hyperpigmented macules associated with chronic ultraviolet exposure and photoaging.
Objective
To describe a standardized 532 nm green laser protocol for solar lentigines and to place these observations within a narrative review with a structured PubMed/Medline literature search.
Methods
Five patients (two women and three men; age range 42–65 years, mean 53.6 years; Fitzpatrick skin phototypes II–III) with solar lentigines underwent treatment with a 532 nm green laser (QuadroStarPRO GREEN, Asclepion) using a standardized, single-session protocol. Outcomes were assessed at the final available follow-up (day 21) by 2 independent dermatologists using a retrospective categorical response classification (complete response/partial response/no response) based on paired baseline and day 21 image documentation only; patient satisfaction was recorded at day 21 on a 0–10 visual analog scale (VAS). A narrative review with a structured PubMed/Medline literature search was conducted to identify clinical studies evaluating 532 nm KTP/green laser devices for lentigines, freckles, and ephelides.
Results
All five target lesions were classified as complete response at day 21 (5/5 complete response), with a mean VAS satisfaction score of 8.6/10 (range, 7–10) and no discordance between dermatologists. Mild transient erythema was observed immediately after treatment and improved within the first day; no persistent adverse events, dyschromia, or scarring were observed during the available 21-day follow-up.
Conclusions
In this small case series, a single-session millisecond 532 nm green laser protocol was associated with complete-response classification at day 21 in five target lesions. Published clinical studies indicate that outcomes with 532 nm devices vary with device type, pulse structure, and treatment settings; larger comparative studies with objective pigment measures and longer follow-ups are needed.
Zitieren
APA
Zappia, E., Cannarozzo, G., Guarino, L., Sannino, M., Gargano, L., Rizzuto, G., Clementi, A., Duca, E. D., Dattola, A., Pellacani, G., & Nisticò, S. P. (2026). Use of a 532 nm Green Laser for Solar Lentigines: Case Series and Review. Cosmetics, 13(3), 128. https://doi.org/10.3390/cosmetics13030128
Vancouver
Zappia E, Cannarozzo G, Guarino L, Sannino M, Gargano L, Rizzuto G, et al. Use of a 532 nm Green Laser for Solar Lentigines: Case Series and Review. Cosmetics. 2026;13(3):128. doi:10.3390/cosmetics13030128
BibTeX
@article{Zappia2026,
author = {Zappia, Elena and Cannarozzo, Giovanni and Guarino, Luca and Sannino, Mario and Gargano, Luca and Rizzuto, Giuseppe and Clementi, Alessandro and Duca, Ester Del and Dattola, Annunziata and Pellacani, Giovanni and Nisticò, Steven Paul},
title = {Use of a 532 nm Green Laser for Solar Lentigines: Case Series and Review},
journal = {Cosmetics},
year = {2026},
volume = {13},
number = {3},
pages = {128},
doi = {10.3390/cosmetics13030128}
}
EUVIMED